These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
187 related items for PubMed ID: 2147689
1. The cytotoxic action of diphtheria toxin and its degradation in intact Vero cells are inhibited by bafilomycin A1, a specific inhibitor of vacuolar-type H(+)-ATPase. Umata T, Moriyama Y, Futai M, Mekada E. J Biol Chem; 1990 Dec 15; 265(35):21940-5. PubMed ID: 2147689 [Abstract] [Full Text] [Related]
2. Japanese encephalitis virus infection in Vero cells: the involvement of intracellular acidic vesicles in the early phase of viral infection was observed with the treatment of a specific vacuolar type H+-ATPase inhibitor, bafilomycin A1. Nawa M. Microbiol Immunol; 1997 Dec 15; 41(7):537-43. PubMed ID: 9272699 [Abstract] [Full Text] [Related]
5. Bafilomycin A1, a specific inhibitor of vacuolar-type H(+)-ATPases, inhibits the receptor-mediated endocytosis of asialoglycoproteins in isolated rat hepatocytes. Harada M, Sakisaka S, Yoshitake M, Kin M, Ohishi M, Shakado S, Mimura Y, Noguchi K, Sata M, Tanikawa K. J Hepatol; 1996 May 15; 24(5):594-603. PubMed ID: 8773916 [Abstract] [Full Text] [Related]
6. [3H]Bafilomycin as a probe for the transmembrane proton channel of the osteoclast vacuolar H(+)-ATPase. Mattsson JP, Keeling DJ. Biochim Biophys Acta; 1996 Apr 03; 1280(1):98-106. PubMed ID: 8634321 [Abstract] [Full Text] [Related]
8. Bafilomycin A1 inhibits IL-1-stimulated proteoglycan degradation by chondrocytes without affecting stromelysin synthesis. Yocum SA, Lopresti-Morrow LL, Gabel CA, Milici AJ, Mitchell PG. Arch Biochem Biophys; 1995 Feb 01; 316(2):827-35. PubMed ID: 7864640 [Abstract] [Full Text] [Related]
9. Bafilomycin A1 inhibits Helicobacter pylori-induced vacuolization of HeLa cells. Papini E, Bugnoli M, De Bernard M, Figura N, Rappuoli R, Montecucco C. Mol Microbiol; 1993 Jan 01; 7(2):323-7. PubMed ID: 8446034 [Abstract] [Full Text] [Related]
10. Inhibition of cell growth by bafilomycin A1, a selective inhibitor of vacuolar H(+)-ATPase. Ohkuma S, Shimizu S, Noto M, Sai Y, Kinoshita K, Tamura H. In Vitro Cell Dev Biol Anim; 1993 Nov 01; 29A(11):862-6. PubMed ID: 8167902 [Abstract] [Full Text] [Related]
11. Vacuolar acidification and bafilomycin-sensitive proton translocating ATPase in human epidermal Langerhans cells. Girolomoni G, Stone DK, Bergstresser PR, Cruz PD. J Invest Dermatol; 1991 May 01; 96(5):735-41. PubMed ID: 1827137 [Abstract] [Full Text] [Related]
12. Inhibitors of vacuolar-type H(+)-ATPase suppresses proliferation of cultured cells. Manabe T, Yoshimori T, Henomatsu N, Tashiro Y. J Cell Physiol; 1993 Dec 01; 157(3):445-52. PubMed ID: 8253855 [Abstract] [Full Text] [Related]
13. Synthesis and structure-activity relationships of bafilomycin A1 derivatives as inhibitors of vacuolar H+-ATPase. Gagliardi S, Gatti PA, Belfiore P, Zocchetti A, Clarke GD, Farina C. J Med Chem; 1998 May 21; 41(11):1883-93. PubMed ID: 9599238 [Abstract] [Full Text] [Related]
14. Relative roles of Na+/H+ exchange and vacuolar-type H+ ATPases in regulating cytoplasmic pH and function in murine peritoneal macrophages. Swallow CJ, Grinstein S, Sudsbury RA, Rotstein OD. J Cell Physiol; 1993 Dec 21; 157(3):453-60. PubMed ID: 8253856 [Abstract] [Full Text] [Related]
16. Effects of bafilomycin A1 on functional capabilities of LPS-activated alveolar macrophages. Bidani A, Heming TA. J Leukoc Biol; 1995 Feb 21; 57(2):275-81. PubMed ID: 7852842 [Abstract] [Full Text] [Related]
17. Retrograde transport from the pre-Golgi intermediate compartment and the Golgi complex is affected by the vacuolar H+-ATPase inhibitor bafilomycin A1. Palokangas H, Ying M, Väänänen K, Saraste J. Mol Biol Cell; 1998 Dec 21; 9(12):3561-78. PubMed ID: 9843588 [Abstract] [Full Text] [Related]